Rigel Pharmaceuticals (RI2.F) Q1 2025 Earnings

4MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.47
-0.06
0.35
0.75

Details

Expected EPS
0.42420008185999997
Actual EPS
0.752872
Surprise EPS
0.33
Surprise Percent
+77.48%

Description

Rigel Pharmaceuticals (RI2.F) has reported earnings of 0.752872 per share for Q1 2025.

0 Comments

Share your thoughts